HROW Harrow Health, Inc.
Platform & Compounding FCF
F 30.0 / 100 pillar composite

AlphaQuality composite grade, weighted for platform & compounding fcf businesses.

⚠ 5 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a platform & compounding fcf business.

Grade overrides the 30.0 pillar composite — hard gates always win.

Profitability

Weight: 25%
D+ 42
  • 5yr Avg ROIC 1.5%
  • Operating Margin Trend +2.62 pp/yr

Capital Efficiency

Weight: 15%
F 0
  • 5yr Avg ROE -56.0%
  • 5yr Share-Count CAGR 7.3%

Growth Quality

Weight: 25%
A+ 100
  • 5yr Revenue CAGR 41.0%
  • Revenue-Growth Years (5) 5/5

Cash Generation

Weight: 20%
F 0
  • 5yr FCF Margin -33.6%
  • 5yr FCF/NI Conversion 0.00x

Balance Sheet

Weight: 10%
D 36
  • Net Debt / EBITDA 4.33x
  • Interest Coverage (EBIT/Int) 0.93x
  • Altman Z-Score 3.15

Stability

Weight: 5%
B+ 76
  • Negative-Revenue Years (5) 0/5
  • Piotroski F-Score 5

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Dumping

0 of 2 gurus held; 2 full exits.

Holders
0 -2
Avg Δ position
New buys
0
Full exits
2
As of Q2 2026